mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.0009 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.43 |
0.001 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |